Neuromodulation for Metabolic Dysfunction
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 120 participants.
Also called NCT07597161
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose other
- Phase
- Not applicable
- Enrolled
- 120 participants
- Sponsor
- Rahul Sachdeva
- Registry
-
NCT07597161
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT07597161. Randomized; single masking; primary purpose other. Start 2026-10-20 (actual); primary completion 2030-05-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Neuromodulation for Metabolic Dysfunction
- Condition
- Spinal Cord Injuries (SCI)
- Condition
- Prediabetes / Type 2 Diabetes
- Intervention (Device)
- Transcutaneous Spinal Cord Stimulation (tSCS)
- Intervention (Device)
- Sham transcutaneous spinal cord stimulation (tSCS)
- Lead sponsor
- Rahul Sachdeva
Record details
- Record id
cardio:ct-nct07597161- Content hash
e66edfeebb5b3142fa3bdd91464ce963c0528211543e3ba31152884ef704b7e5